Frontiers in Oncology | Thoracic Oncology

Original Research

Accepted on 15 Oct 2025

Preoperative plasma fibrinogen combined with the platelet-to-lymphocyte ratio (F-PLR) serves as a prognostic indicator in patients with non-small cell lung cancer

in Thoracic Oncology

Hongzhen Zhao
Xiaopeng Zhang
Dahu Ren
Shicheng Liu
Yuedong Wang
Wenbo Wu
Kun Zhang
Yajing Niu
Guochen Duan

Frontiers in Oncology

doi 10.3389/fonc.2025.1587443

Review

Published on 15 Oct 2025

Balancing oncological control and immune preservation in the immunotherapy era: revisiting lymph node dissection in non-small cell lung cancer

in Thoracic Oncology

Tao Jing
Jianbao Yang
Xiaoping Wei
Cheng Wang
Bin Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1652551

677 views

Case Report

Published on 15 Oct 2025

Rosai-Dorfman disease mimicking lung cancer: a case report

in Thoracic Oncology

Caijuan Zhang
Ruoling Gao
Zhenwei Chen
Zhilan Huang
Tian Yang
Ji Bo Hu

Frontiers in Oncology

doi 10.3389/fonc.2025.1663537

194 views

Original Research

Published on 15 Oct 2025

CT-based habitat radiomics for preoperative differentiation of adenocarcinoma in situ/minimally invasive adenocarcinoma from invasive adenocarcinoma manifesting as ground-glass nodules: a multicenter study

in Thoracic Oncology

Ning Dong
Yumao Yan
Yunxin Li
Guochao Li
Ping Wang
Lin Li
Hu Zhang
Hui Sheng
Xiaoyuan Sun

Frontiers in Oncology

doi 10.3389/fonc.2025.1660071

744 views

Original Research

Published on 14 Oct 2025

Trajectories of perioperative serum CEA and non-small cell lung cancer prognosis: a retrospective longitudinal cohort study

in Thoracic Oncology

Yuyang Ma
Xiaoyin Pan
Jiameng Cui
Wanzhu Lu
Gege Sun
Junlong Pan
Xiao Dong
Kejia Hu
Wenyuan Li
Huakang Tu

Frontiers in Oncology

doi 10.3389/fonc.2025.1627122

422 views

Case Report

Published on 14 Oct 2025

Pathological complete response to conversion therapy for lung adenocarcinoma with brain metastasis: a case report

in Thoracic Oncology

Xingqiang Ran
Tao Luo
Jie Xiong
Maoyong Fu

Frontiers in Oncology

doi 10.3389/fonc.2025.1625918

418 views

Original Research

Published on 14 Oct 2025

Interstitial pneumonia microenvironment promotes metastasis to the mediastinal lymph nodes and lungs

in Thoracic Oncology

Ryo Maeda
Mayu Inomata
Ryusei Yamada

Frontiers in Oncology

doi 10.3389/fonc.2025.1657948

627 views

Case Report

Accepted on 13 Oct 2025

Evolution and Targeted Therapy of an EGFR-Mutant Large-Cell Neuroendocrine Carcinoma: A Case Report

in Thoracic Oncology

Jiang Li
Pengfei Li
Xiaowen Yao
Xiuyu Cai

Frontiers in Oncology

doi 10.3389/fonc.2025.1599765

Review

Accepted on 13 Oct 2025

Advances in modelling the risk of benign and malignant lung nodules

in Thoracic Oncology

Shang Du
Tangwei Wu
Hui Wang
Zheqiong Tan
Zhongxin Lu

Frontiers in Oncology

doi 10.3389/fonc.2025.1648548

Original Research

Accepted on 13 Oct 2025

MiR-4664-3p as a Potential Diagnostic, Prognostic, and Immunotherapeutic Biomarker in NSCLC: Modulation of Tumor Progression through CD8 + T Cell Regulation

in Thoracic Oncology

Chun Yi
Hao Zhang
Qianqian Guo
Linzhu Lu
Cong Gao
Yunlong Zhao
Yan Su
Jing Lu

Frontiers in Oncology

doi 10.3389/fonc.2025.1642999

Original Research

Accepted on 13 Oct 2025

Analysis of short-term clinical efficacy and immune function changes of advanced non-small cell lung cancer after radiotherapy or chemotherapy under CT-guided 125Ⅰseed implantation

in Thoracic Oncology

Yunfeng Kou
Songbai Chen
Yuting Yuan
Guangsheng Zhao
Jun Zhou
Zhe Wang
Ruoyu Wang
Chuang Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1667205

Case Report

Published on 13 Oct 2025

Durable clinical benefit from gefitinib plus bevacizumab in a non-small cell lung cancer patient with an acquired C797S mutation following osimertinib treatment: a case report and literature review

in Thoracic Oncology

Yuping Tan
Meng Dong
Xi Li
Wenbo Li
Fei Xiong
Weidong Bao
Yongzhou Dai
Linjun Yue
Yuan Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1673836

589 views

Original Research

Published on 13 Oct 2025

Deep learning radiomics model of epicardial adipose tissue for predicting postoperative atrial fibrillation after lung lobectomy in lung cancer patients

in Thoracic Oncology

Zhan Liu
Chong Zheng
Zongxiao Jia
Chengwei Zhao
Xiangyu Liu
Weipeng Shao
Feng Chen
Hui Zhu
Hongbo Guo

Frontiers in Oncology

doi 10.3389/fonc.2025.1623248

865 views

Original Research

Accepted on 10 Oct 2025

Effects of Evidence-Based Nursing Under a Quantitative Assessment Strategy on Cancer-Related Fatigue, Self-Management Ability, and Quality of Life in Lung Cancer Patients Undergoing Chemotherapy

in Thoracic Oncology

Liwei Zhang
Haixian Fang
Yongqian Zhang
Xin Su
Juan Zhang
Li He
Changwen Bo
Yusha Yan
Jing Liu
Feifei Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1685591

105 views

Case Report

Accepted on 10 Oct 2025

Primary leiomyosarcoma originating from the azygos vein misdiagnosed as tracheal tumor: a case report and literature review

in Thoracic Oncology

Longfei Zhu
YuJun Wang
Chunjian Zuo
YuanLin Deng
Bin Jiang

Frontiers in Oncology

doi 10.3389/fonc.2025.1639131

109 views

Review

Accepted on 10 Oct 2025

Unlocking the potential of immunotherapy for patients with resectable non–small cell lung cancer

in Thoracic Oncology

Sandip Pravin Patel
Justin Gainor
Steven Kao
Se-Hoon Lee
Tony Mok
Riyaz Shah
Caicun Zhou
Solange Peters

Frontiers in Oncology

doi 10.3389/fonc.2025.1690367

219 views